Selected research
Industry Research
Intravenous Nutritional Product Industry Research Report 2026
Market perspective
The global Intravenous Nutritional Product market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Intravenous Nutritional Product market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Intravenous Nutritional Product market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Intravenous Nutritional Product market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Intravenous Nutritional Product include Xi'an Libang Pharmaceutical, Weixinkang, B. Braun, Baxter, Otsuka Pharmaceutical, Lummy, Lionco Pharmaceutical, King York and Kelun Pharma, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Intravenous Nutritional Product market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Intravenous Nutritional Product.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Intravenous Nutritional Product Market by Company
Xi'an Libang Pharmaceutical
Weixinkang
B. Braun
Baxter
Otsuka Pharmaceutical
Lummy
Lionco Pharmaceutical
King York
Kelun Pharma
JW Pharmaceutical
Haisco Pharmaceutical Group
Grifols
Grand Life Sciences
Fresenius Kabi
Cisen
China Meheco Kangli
Biokin Pharmaceutical
BBCA Pharmaceutical
Baizheng Pharmaceutical
Aguettant
Intravenous Nutritional Product Segment by Type
Amino Acid
Alanyl-Glutamine
Heat and Fat Emulsion
Trace Elements
Vitamins
Intravenous Nutritional Product Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Others
Intravenous Nutritional Product Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Nutritional Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intravenous Nutritional Product and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Nutritional Product.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Intravenous Nutritional Product companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Amino Acid
- Alanyl-Glutamine
- Heat and Fat Emulsion
- Trace Elements
- Vitamins
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- Others
Companies covered
- Xi'an Libang Pharmaceutical
- Weixinkang
- B. Braun
- Baxter
- Otsuka Pharmaceutical
- Lummy
- Lionco Pharmaceutical
- King York
- Kelun Pharma
- JW Pharmaceutical
- Haisco Pharmaceutical Group
- Grifols
- Grand Life Sciences
- Fresenius Kabi
- Cisen
- China Meheco Kangli
- Biokin Pharmaceutical
- BBCA Pharmaceutical
- Baizheng Pharmaceutical
- Aguettant
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Intravenous Nutritional Product by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Amino Acid
- 2.2.3 Alanyl-Glutamine
- 2.2.4 Heat and Fat Emulsion
- 2.2.5 Trace Elements
- 2.2.6 Vitamins
- 2.3 Intravenous Nutritional Product by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital Pharmacies
- 2.3.3 Online Pharmacies
- 2.3.4 Retail Pharmacies
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Intravenous Nutritional Product Breakdown Data by Type
- 3.1 Global Intravenous Nutritional Product Historic Market Size by Type (2021-2026)
- 3.2 Global Intravenous Nutritional Product Forecasted Market Size by Type (2027-2032)
4 Intravenous Nutritional Product Breakdown Data by Application
- 4.1 Global Intravenous Nutritional Product Historic Market Size by Application (2021-2026)
- 4.2 Global Intravenous Nutritional Product Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Intravenous Nutritional Product Market Perspective (2021-2032)
- 5.2 Global Intravenous Nutritional Product Growth Trends by Region
- 5.2.1 Global Intravenous Nutritional Product Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Intravenous Nutritional Product Historic Market Size by Region (2021-2026)
- 5.2.3 Intravenous Nutritional Product Forecasted Market Size by Region (2027-2032)
- 5.3 Intravenous Nutritional Product Market Dynamics
- 5.3.1 Intravenous Nutritional Product Industry Trends
- 5.3.2 Intravenous Nutritional Product Market Drivers
- 5.3.3 Intravenous Nutritional Product Market Challenges
- 5.3.4 Intravenous Nutritional Product Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Intravenous Nutritional Product Players by Revenue
- 6.1.1 Global Top Intravenous Nutritional Product Players by Revenue (2021-2026)
- 6.1.2 Global Intravenous Nutritional Product Revenue Market Share by Players (2021-2026)
- 6.2 Global Intravenous Nutritional Product Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Intravenous Nutritional Product Head Office and Area Served
- 6.4 Global Intravenous Nutritional Product Players, Product Type & Application
- 6.5 Global Intravenous Nutritional Product Manufacturers Established Date
- 6.6 Global Intravenous Nutritional Product Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Intravenous Nutritional Product Market Size (2021-2032)
- 7.2 North America Intravenous Nutritional Product Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Intravenous Nutritional Product Market Size by Country (2021-2026)
- 7.4 North America Intravenous Nutritional Product Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Intravenous Nutritional Product Market Size (2021-2032)
- 8.2 Europe Intravenous Nutritional Product Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Intravenous Nutritional Product Market Size by Country (2021-2026)
- 8.4 Europe Intravenous Nutritional Product Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Intravenous Nutritional Product Market Size (2021-2032)
- 9.2 Asia-Pacific Intravenous Nutritional Product Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Intravenous Nutritional Product Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Intravenous Nutritional Product Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Intravenous Nutritional Product Market Size (2021-2032)
- 10.2 South America Intravenous Nutritional Product Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Intravenous Nutritional Product Market Size by Country (2021-2026)
- 10.4 South America Intravenous Nutritional Product Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Intravenous Nutritional Product Market Size (2021-2032)
- 11.2 Middle East & Africa Intravenous Nutritional Product Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Intravenous Nutritional Product Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Intravenous Nutritional Product Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Xi'an Libang Pharmaceutical
- 12.1.1 Xi'an Libang Pharmaceutical Company Information
- 12.1.2 Xi'an Libang Pharmaceutical Business Overview
- 12.1.3 Xi'an Libang Pharmaceutical Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.1.4 Xi'an Libang Pharmaceutical Intravenous Nutritional Product Product Portfolio
- 12.1.5 Xi'an Libang Pharmaceutical Recent Developments
- 12.2 Weixinkang
- 12.2.1 Weixinkang Company Information
- 12.2.2 Weixinkang Business Overview
- 12.2.3 Weixinkang Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.2.4 Weixinkang Intravenous Nutritional Product Product Portfolio
- 12.2.5 Weixinkang Recent Developments
- 12.3 B. Braun
- 12.3.1 B. Braun Company Information
- 12.3.2 B. Braun Business Overview
- 12.3.3 B. Braun Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.3.4 B. Braun Intravenous Nutritional Product Product Portfolio
- 12.3.5 B. Braun Recent Developments
- 12.4 Baxter
- 12.4.1 Baxter Company Information
- 12.4.2 Baxter Business Overview
- 12.4.3 Baxter Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.4.4 Baxter Intravenous Nutritional Product Product Portfolio
- 12.4.5 Baxter Recent Developments
- 12.5 Otsuka Pharmaceutical
- 12.5.1 Otsuka Pharmaceutical Company Information
- 12.5.2 Otsuka Pharmaceutical Business Overview
- 12.5.3 Otsuka Pharmaceutical Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.5.4 Otsuka Pharmaceutical Intravenous Nutritional Product Product Portfolio
- 12.5.5 Otsuka Pharmaceutical Recent Developments
- 12.6 Lummy
- 12.6.1 Lummy Company Information
- 12.6.2 Lummy Business Overview
- 12.6.3 Lummy Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.6.4 Lummy Intravenous Nutritional Product Product Portfolio
- 12.6.5 Lummy Recent Developments
- 12.7 Lionco Pharmaceutical
- 12.7.1 Lionco Pharmaceutical Company Information
- 12.7.2 Lionco Pharmaceutical Business Overview
- 12.7.3 Lionco Pharmaceutical Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.7.4 Lionco Pharmaceutical Intravenous Nutritional Product Product Portfolio
- 12.7.5 Lionco Pharmaceutical Recent Developments
- 12.8 King York
- 12.8.1 King York Company Information
- 12.8.2 King York Business Overview
- 12.8.3 King York Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.8.4 King York Intravenous Nutritional Product Product Portfolio
- 12.8.5 King York Recent Developments
- 12.9 Kelun Pharma
- 12.9.1 Kelun Pharma Company Information
- 12.9.2 Kelun Pharma Business Overview
- 12.9.3 Kelun Pharma Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.9.4 Kelun Pharma Intravenous Nutritional Product Product Portfolio
- 12.9.5 Kelun Pharma Recent Developments
- 12.10 JW Pharmaceutical
- 12.10.1 JW Pharmaceutical Company Information
- 12.10.2 JW Pharmaceutical Business Overview
- 12.10.3 JW Pharmaceutical Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.10.4 JW Pharmaceutical Intravenous Nutritional Product Product Portfolio
- 12.10.5 JW Pharmaceutical Recent Developments
- 12.11 Haisco Pharmaceutical Group
- 12.11.1 Haisco Pharmaceutical Group Company Information
- 12.11.2 Haisco Pharmaceutical Group Business Overview
- 12.11.3 Haisco Pharmaceutical Group Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.11.4 Haisco Pharmaceutical Group Intravenous Nutritional Product Product Portfolio
- 12.11.5 Haisco Pharmaceutical Group Recent Developments
- 12.12 Grifols
- 12.12.1 Grifols Company Information
- 12.12.2 Grifols Business Overview
- 12.12.3 Grifols Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.12.4 Grifols Intravenous Nutritional Product Product Portfolio
- 12.12.5 Grifols Recent Developments
- 12.13 Grand Life Sciences
- 12.13.1 Grand Life Sciences Company Information
- 12.13.2 Grand Life Sciences Business Overview
- 12.13.3 Grand Life Sciences Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.13.4 Grand Life Sciences Intravenous Nutritional Product Product Portfolio
- 12.13.5 Grand Life Sciences Recent Developments
- 12.14 Fresenius Kabi
- 12.14.1 Fresenius Kabi Company Information
- 12.14.2 Fresenius Kabi Business Overview
- 12.14.3 Fresenius Kabi Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.14.4 Fresenius Kabi Intravenous Nutritional Product Product Portfolio
- 12.14.5 Fresenius Kabi Recent Developments
- 12.15 Cisen
- 12.15.1 Cisen Company Information
- 12.15.2 Cisen Business Overview
- 12.15.3 Cisen Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.15.4 Cisen Intravenous Nutritional Product Product Portfolio
- 12.15.5 Cisen Recent Developments
- 12.16 China Meheco Kangli
- 12.16.1 China Meheco Kangli Company Information
- 12.16.2 China Meheco Kangli Business Overview
- 12.16.3 China Meheco Kangli Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.16.4 China Meheco Kangli Intravenous Nutritional Product Product Portfolio
- 12.16.5 China Meheco Kangli Recent Developments
- 12.17 Biokin Pharmaceutical
- 12.17.1 Biokin Pharmaceutical Company Information
- 12.17.2 Biokin Pharmaceutical Business Overview
- 12.17.3 Biokin Pharmaceutical Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.17.4 Biokin Pharmaceutical Intravenous Nutritional Product Product Portfolio
- 12.17.5 Biokin Pharmaceutical Recent Developments
- 12.18 BBCA Pharmaceutical
- 12.18.1 BBCA Pharmaceutical Company Information
- 12.18.2 BBCA Pharmaceutical Business Overview
- 12.18.3 BBCA Pharmaceutical Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.18.4 BBCA Pharmaceutical Intravenous Nutritional Product Product Portfolio
- 12.18.5 BBCA Pharmaceutical Recent Developments
- 12.19 Baizheng Pharmaceutical
- 12.19.1 Baizheng Pharmaceutical Company Information
- 12.19.2 Baizheng Pharmaceutical Business Overview
- 12.19.3 Baizheng Pharmaceutical Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.19.4 Baizheng Pharmaceutical Intravenous Nutritional Product Product Portfolio
- 12.19.5 Baizheng Pharmaceutical Recent Developments
- 12.20 Aguettant
- 12.20.1 Aguettant Company Information
- 12.20.2 Aguettant Business Overview
- 12.20.3 Aguettant Revenue in Intravenous Nutritional Product Business (2021-2026)
- 12.20.4 Aguettant Intravenous Nutritional Product Product Portfolio
- 12.20.5 Aguettant Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst